However, mutations are also commonly present in KRAS Q61 (2%), K117 (1%), and A146 (4%).4,5,14 Here, we investigated clinical features like tumor load and overall survival of patients with mCRC with a somatic mutation in KRAS G12, G13, Q61, K117, or A146. Here, KRAS is linked to neoplasm.